4//SEC Filing
Ramachandran Niro Ph.D 4
Accession 0001104659-23-023346
CIK 0001711933other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:10 PM ET
Size
7.0 KB
Accession
0001104659-23-023346
Insider Transaction Report
Form 4
Ramachandran Niro Ph.D
Chief Business Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-02-15−34,000→ 62,566 totalExercise: $0.91Exp: 2030-03-23→ Common Stock (34,000 underlying) - Exercise/Conversion
Common Stock
2023-02-15$0.91/sh+34,000$30,940→ 156,680 total
Footnotes (1)
- [F1]The option vested as follows: one-fourth (1/4) of the shares on July 13, 2021 and the remaining shares shall vest in 36 equal monthly installments beginning on July 13, 2021, until fully vested, subject to reporting person's continuous employment.
Documents
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001857443
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 5:10 PM ET
- Size
- 7.0 KB